Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RCC cell lines express distinct levels of cell adhesion proteins and the forced over-expression of Rap1GAP attenuated levels of both cadherins and integrins that are known to regulate the cancer cells invasion.
|
22266190 |
2012 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RCC cell lines express distinct levels of cell adhesion proteins and the forced over-expression of Rap1GAP attenuated levels of both cadherins and integrins that are known to regulate the cancer cells invasion.
|
22266190 |
2012 |
Refractory Cytopenia of Childhood
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RCC cell lines express distinct levels of cell adhesion proteins and the forced over-expression of Rap1GAP attenuated levels of both cadherins and integrins that are known to regulate the cancer cells invasion.
|
22266190 |
2012 |
Squamous cell carcinoma of oropharynx
|
0.010 |
Biomarker
|
disease |
BEFREE |
Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.
|
16436672 |
2006 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Rap1GAP down-regulation is due to its promoter methylation, a mechanism of gene silencing in tumors.
|
19147557 |
2009 |
Tumor Cell Invasion
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
Rap1GAP downregulation was required in vitro for cell migration and Matrigel invasion.
|
20124489 |
2010 |
Squamous cell carcinoma of the head and neck
|
0.010 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is a critical tumor suppressor gene that is downregulated in multiple aggressive cancers, such as head and neck squamous cell carcinoma, melanoma and pancreatic cancer.
|
21532618 |
2011 |
Malignant neoplasm of pancreas
|
0.330 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is a critical tumor suppressor gene that is downregulated in multiple aggressive cancers, such as head and neck squamous cell carcinoma, melanoma and pancreatic cancer.
|
21532618 |
2011 |
Pancreatic carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is a critical tumor suppressor gene that is downregulated in multiple aggressive cancers, such as head and neck squamous cell carcinoma, melanoma and pancreatic cancer.
|
21532618 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Tumor Progression
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Malignant neoplasm of pancreas
|
0.330 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Malignant neoplasm of pancreas
|
0.330 |
Biomarker
|
disease |
CTD_human |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Pancreatic carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Thyroid Neoplasm
|
0.350 |
Biomarker
|
disease |
CTD_human |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Thyroid Neoplasm
|
0.350 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Thyroid carcinoma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Thyroid carcinoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Malignant neoplasm of thyroid
|
0.030 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
melanoma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
melanoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Thyroid carcinoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells.
|
22696507 |
2012 |
Malignant neoplasm of thyroid
|
0.030 |
Biomarker
|
disease |
BEFREE |
RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells.
|
22696507 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rap1GAP is a crucial tumor suppressor, but its role in gastric cancer (GC) is little investigated.
|
28009991 |
2017 |